Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor? (Q54335282)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 August 2014

Language	Label	Description	Also known as
English	Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?	scientific article published on 27 August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

chronic myeloid leukemia

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Joaquin Martinez-Lopez

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jose-Angel Hernandez-Rivas

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Valentin García-Gutiérrez

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jose Manuel Puerta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Begoña Maestro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Luis Felipe Casado Montero

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jose Ramon Molina Hurtado

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Manuel Perez-Encinas

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Victoria Moreno Romero

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Pere Barba Suñol

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ricardo Sola Garcia

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Raquel De Paz

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Jose Ramirez Sanchez

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Santiago Osorio

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Isabel Mata Vazquez

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jose Luis Sastre

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria de Los Angles Portero

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Guiomar Bautista

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Soledad Duran Nieto

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Pilar Giraldo

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Margarita Jimenez Jambrina

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Carmen Burgaleta

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Joaquin Ruiz Aredondo

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria Jesús Peñarrubia

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria José Requena

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

María Del Carmen Fernández Valle

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Carmen Calle

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Antonio Paz Coll

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rafael Franco Osorio

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Pilar Cano

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

David Tallón Pérez

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Margarita Fernández de la Mata

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Pilar López Garrido

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Juan Luis Steegmann

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

27 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

89

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

E206-11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25059397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23816

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54335282&oldid=1133249851"